AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca FluMist / Fluenz (influenza vaccine) by Year
FluMist / Fluenz (influenza vaccine) — Europe product sales ($M) ($M)
AstraZeneca FluMist / Fluenz (influenza vaccine): $210M in FY2025, up 2.9% from a year earlier.
Where the FY2025 figure comes from
“|| FluMist | 272 | 6 | 3 | 28 | 1 | 5 | n/m | n/m | 210 | 3 | (1) | 29 | 19 | 19”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | FluMist / Fluenz (influenza vaccine) — Europe product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 210 | +2.9% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 204 | +8.5% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 188 | +24.5% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 151 | -32.0% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 222 | +1.4% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 219 | – | Form 6-K FY2020Q4 Earnings Release ↗ |
Breakdown
What makes up fluMist / Fluenz (influenza vaccine)
Cite this data
StockData. (2026). AstraZeneca FluMist / Fluenz (influenza vaccine) ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-flumist-eu
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.